Retroperitoneal Bulky Histiocytic Sarcoma Successfully Treated with Induction Chemotherapy Followed by Curative Surgery

Intern Med. 2017 Oct 15;56(20):2765-2768. doi: 10.2169/internalmedicine.8000-16. Epub 2017 Sep 15.

Abstract

Histiocytic sarcoma (HS) is a rare hematopoietic neoplasm. We report a patient with HS treated with induction chemotherapy followed by curative surgery. A 50-year-old man was referred to our hospital because of a retroperitoneal tumor. A computed tomography scan revealed a bulky retroperitoneal mass, infiltrating the surrounding organ. An excisional biopsy confirmed the diagnosis of HS. The tumor shrunk after multidrug chemotherapy. However, positron emission tomography showed uptake of fludeoxyglucose in the residual tumor. He underwent right nephrectomy to remove the tumor. Pathological examination showed complete response. Surgery combined with induction chemotherapy may be an effective way to manage HS.

Keywords: chemotherapy; histiocytic sarcoma; surgery.

Publication types

  • Case Reports

MeSH terms

  • Biopsy
  • Fluorodeoxyglucose F18
  • Histiocytic Sarcoma / diagnosis
  • Histiocytic Sarcoma / drug therapy*
  • Histiocytic Sarcoma / pathology
  • Histiocytic Sarcoma / surgery*
  • Humans
  • Induction Chemotherapy / methods*
  • Male
  • Middle Aged
  • Positron-Emission Tomography
  • Remission Induction
  • Retroperitoneal Neoplasms / diagnosis
  • Retroperitoneal Neoplasms / drug therapy*
  • Retroperitoneal Neoplasms / pathology
  • Retroperitoneal Neoplasms / surgery*
  • Tomography, X-Ray Computed

Substances

  • Fluorodeoxyglucose F18